The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Multidrug resistance: molecular mechanisms and clinical relevance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
The ATP-dependent glutathione S-conjugate export pump
Ishikawa, T. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90489-v · Cited by 654
Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G., Taylor, C. W., Miller, T. P., & Salmon, S. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.415 · Cited by 556
Chan, H. S., Thorner, P. S., Haddad, G., & Ling, V (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.4.689 · Cited by 451
Self-citationBeck, W. T., Grogan, T. M., Willman, C. L., Cordon‐Cardo, C., Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., et al. (1996) · PubMed · Cited by 384
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.10.708 · Cited by 355
Modulation of multidrug-resistant multiple myeloma by cyclosporin
Sonneveld, P., Lowenberg, B., Durie, B. G. M., Lokhorst, H. M., Marie, J.-P., Zittoun, R., Solbu, G., Suciu, S., & Nooter, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92353-h · Cited by 316
BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance
Reed, J. C. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30104-7 · Cited by 316
Glutathione S-transferases and drug resistance
(1991) · International Journal of Biochemistry · doi:10.1016/0020-711x(91)90023-g · Cited by 305
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
List, A. F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M., & Dalton, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1652 · Cited by 274
Ishikawa, T., Bao, J.-J., Yamane, Y., Akimaru, K., Frindrich, K., Wright, C. D., & Kuo, M. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14981 · Cited by 266
P-glycoprotein, multidrug resistance and tumor progression
Bradley, G., & Ling, V. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689638 · Cited by 195
Self-citationChan, H. S. L., Deboer, G., Thiessen, J. J., et al. (1996) · PubMed · Cited by 138
Multidrug Resistance and Chemosensitization: Therapeutic Implications for Cancer Chemotherapy
Georges, E., Sharom, F. J., & Ling, V. W. T. (1990) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60343-9 · Cited by 117
Self-citationWhat have we learnt thus far from mice with disrupted P-glycoprotein genes?
Borst, P., & Schinkel, A. H. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00063-9 · Cited by 109
Icreased drug permeability in Chinese hamster ovary cells in the presence of cyanide
See, Y. P., Carlsen, S. A., Till, J. E., & Ling, V. W. T. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90148-5 · Cited by 81
Self-citationUsing purified P-glycoprotein to understand multidrug resistance
Shapiro, A. B., & Ling, V. W. T. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110325 · Cited by 66
Self-citationP-glycoprotein in Adult Hematologic Malignancies
Marie, J. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30094-7 · Cited by 65
Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines.
Hs, C., Canton, & Gallie, B. L. (1989) · PubMed · Cited by 62
Multidrug-Resistant Gene Expression in Small-Cell Lung Cancer
Savaraj, N., Wu, C. J., Xu, R., Lampidis, T. J., Lai, S., Donnelly, E., Solomon, J., & Feun, L. G. (1997) · American Journal of Clinical Oncology · doi:10.1097/00000421-199708000-00016 · Cited by 42
Cited by
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
The role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1728 · Cited by 900
Siddiqui, A., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 665
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Metadata
- Authors
- Ling, V.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 1997-06-02
- Volume
- 40
- Issue
- 7
- Pages
- S3-S8
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W1993176598
- Cited by
- 522
- References
- 23
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.